Gene Therapy for Hemophilia*

Publisher： Karger

E-ISSN： 1660-3818|33|2|165-168

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.33, Iss.2, 2006-03, pp. : 165-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New approaches to gene and cell therapy for hemophilia

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S133-S142

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gene therapy in an era of emerging treatment options for hemophilia B

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. S1, 2015-06 ,pp. : S151-S160

John Wiley & Sons Inc

Access to resources Recommend Favorite

The important role of von Willebrand factor in platelet‐derived FVIII gene therapy for murine hemophilia A in the presence of inhibitory antibodies

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 7, 2015-07 ,pp. : 1301-1309

John Wiley & Sons Inc

Access to resources Recommend Favorite

Current Issues in Prophylactic Therapy for Persons with Hemophilia

By  

Acta Haematologica, Vol. 115, Iss. 3-4, 2006-03 ,pp. : 162-171

Karger

Access to resources Recommend Favorite

Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B

By  

JOURNAL OF CARDIAC SURGERY (ELECTRONIC), Vol. 33, Iss. 2, 2018-02 ,pp. : 76-82

John Wiley & Sons Inc

Access to resources Recommend Favorite